E-LIB Suche - Ergebnisse für: Garmezy, Benjamin

1

A Phase I Study of KIN-3248, an Irreversible Small-molecule..:

Garmezy, Benjamin ; Borad, Mitesh J. ; Bahleda, Rastilav...
Cancer Research Communications. 4 (2024) 4 - p. 1165-1173 , 2024

Link: https://doi.org/10.1158/..

2

Phase 1/2 study of PRO1160, a CD70-directed antibody-drug c..:

Jonasch, Eric ; Call, Justin ; Kambhampati, Swetha...
The Oncologist. 28 (2023) Supplement_1 - p. S14-S15 , 2023

Link: https://doi.org/10.1093/..

3

Zanzalintinib in combination with immune checkpoint inhibit..:

Motzer, Robert J ; Choueiri, Toni K ; Garmezy, Benjamin...
The Oncologist. 28 (2023) Supplement_1 - p. S10-S11 , 2023

Link: https://doi.org/10.1093/..

4

Combination antiangiogenic tyrosine kinase inhibition and a..:

Laccetti, Andrew L. ; Garmezy, Benjamin ; Xiao, Lianchun...
Cancer Medicine. 10 (2021) 7 - p. 2341-2349 , 2021

Link: https://doi.org/10.1002/..

5

All bone metastases are not created equal: Revisiting treat..:

Brozovich, Ava ; Garmezy, Benjamin ; Pan, Tianhong...
Journal of Bone Oncology. 31 (2021) - p. 100399 , 2021

Link: https://doi.org/10.1016/..

6

A provider's guide to primary myelofibrosis: pathophysiolog..:

Garmezy, Benjamin ; Schaefer, Jordan K. ; Mercer, Jessica.
Blood Reviews. 45 (2021) - p. 100691 , 2021

Link: https://doi.org/10.1016/..

7

Characterization of Mortality in Myelofibrosis:

Garmezy, Benjamin ; Boonstra, Phillip ; Kandarpa, Malathi.
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) - p. S353 , 2017

Link: https://doi.org/10.1016/..

8

Poster 437 Pain in Spinal Cord Injury ‐ An Unusual Presenta..:

Thakur, Siddarth ; Garmezy, Benjamin ; Linville, Cole R...
PM&R. 8 (2016) 9S - p. , 2016

Link: https://doi.org/10.1016/..

9

Differentiating Skin-Limited and Multisystem Langerhans Cel..:

Simko, Stephen J. ; Garmezy, Benjamin ; Abhyankar, Harshal...
The Journal of Pediatrics. 165 (2014) 5 - p. 990-996 , 2014

Link: https://doi.org/10.1016/..

10

Phase 1/2 study of PRO1160, a CD70-directed antibody-drug c..:

Jonasch, Eric ; Call, Justin ; Kambhampati, Swetha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445573/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Zanzalintinib in combination with immune checkpoint inhibit..:

Motzer, Robert J ; Choueiri, Toni K ; Garmezy, Benjamin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445562/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Clinical and Molecular Characterization of POLE Mutations a..:

Garmezy, Benjamin ; Gheeya, Jinesh ; Lin, Heather Y...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820927/. , 2022

Link: http://www.ncbi.nlm.nih...

13

All bone metastases are not created equal: Revisiting treat..:

Brozovich, Ava ; Garmezy, Benjamin ; Pan, Tianhong...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551072/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Combination antiangiogenic tyrosine kinase inhibition and a..:

Laccetti, Andrew L ; Garmezy, Benjamin ; Xiao, Lianchun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982609/. , 2021

Link: http://www.ncbi.nlm.nih...

15

764 A phase 1, first-in-human (FIH), open-label, dose-findi..:

Benjamin Thompson ; Li Yao ; Yana G Najjar...
https://doaj.org/toc/2051-1426. , 2023

Link: https://doi.org/10.1136/..